Search research articles
Contact Us
Filters
Showing results (61-70 of 72) with videos related to
Page
of 8
Sort By:
The Journal of Allergy and Clinical Immunology
|
December 5, 2021
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
Emma Guttman-Yassky, Ana B Pavel, Aisleen Diaz, et al.
Journal of the American Academy of Dermatology
|
August 12, 2015
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series
Vivian Y Shi, Khiem Tran, Forum Patel, et al.
Pharmacology Research & Perspectives
|
July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
Samira Anderson, Guido Cavaletti, Linda J Hood, et al.
Journal of the American Academy of Dermatology
|
November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial
Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
Nature Communications
|
June 6, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
William Damsky, Alice Wang, Daniel J Kim, et al.
Journal of the American Academy of Dermatology
|
April 29, 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis
Eric Simpson, Robert Bissonnette, Lawrence F Eichenfield, et al.
Journal of the American Academy of Dermatology
|
March 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
Nekma Meah, Dmitri Wall, Katherine York, et al.
Journal of the American Academy of Dermatology
|
September 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata
Nekma Meah, Dmitri Wall, Katherine York, et al.
JAMA Dermatology
|
March 3, 2021
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)
Dmitri Wall, Nekma Meah, Katherine York, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 23, 2025
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Nekma Meah, Jane Li, Dmitri Wall, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 72) with videos related to
Sort By:
Page
of 8
The Journal of Allergy and Clinical Immunology
|
December 5, 2021
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkers
Emma Guttman-Yassky, Ana B Pavel, Aisleen Diaz, et al.
Journal of the American Academy of Dermatology
|
August 12, 2015
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case series
Vivian Y Shi, Khiem Tran, Forum Patel, et al.
Pharmacology Research & Perspectives
|
July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areata
Samira Anderson, Guido Cavaletti, Linda J Hood, et al.
Journal of the American Academy of Dermatology
|
November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial
Khaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.
Nature Communications
|
June 6, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis
William Damsky, Alice Wang, Daniel J Kim, et al.
Journal of the American Academy of Dermatology
|
April 29, 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitis
Eric Simpson, Robert Bissonnette, Lawrence F Eichenfield, et al.
Journal of the American Academy of Dermatology
|
March 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areata
Nekma Meah, Dmitri Wall, Katherine York, et al.
Journal of the American Academy of Dermatology
|
September 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areata
Nekma Meah, Dmitri Wall, Katherine York, et al.
JAMA Dermatology
|
March 3, 2021
A Global eDelphi Exercise to Identify Core Domains and Domain Items for the Development of a Global Registry of Alopecia Areata Disease Severity and Treatment Safety (GRASS)
Dmitri Wall, Nekma Meah, Katherine York, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV
|
July 23, 2025
Statement from the frontal fibrosing alopecia international expert alliance: SOFFIA 2024
Nekma Meah, Jane Li, Dmitri Wall, et al.
Page
of 8